NFSG
CUE icon

Newbridge Financial Services Group’s Cue Biopharma CUE Stock Holding History

Newbridge Financial Services Group’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$690 Hold
100
– – ﹤0.01% 1098
2025
Q4 		$916 Hold
100
– – ﹤0.01% 1085
2025
Q3 		$2.16K Hold
100
– – ﹤0.01% 1126
2025
Q2 		$2.05K Sell
100
-17
-15% -$363 ﹤0.01% 1136
2025
Q1 		$3.19K Buy
117
+17
+17% +$631 ﹤0.01% 845
2024
Q4 		$3.27K Hold
100
– – ﹤0.01% 913
2024
Q3 		$2.27K Hold
100
– – ﹤0.01% 558
2024
Q2 		$3.72K Hold
100
– – ﹤0.01% 888
2024
Q1 		$5.67K Hold
100
– – ﹤0.01% 868
2023
Q4 		$7.92K Sell
100
-33
-25% -$2.36K ﹤0.01% 789
2023
Q3 		$9.2K Sell
133
-34
-20% -$3.32K ﹤0.01% 836
2023
Q2 		$18.3K Hold
167
– – 0.01% 722
2023
Q1 		$17.9K Sell
167
-400
-71% -$38.1K 0.01% 766
2022
Q4 		$48.5K Hold
567
– – 0.03% 472
2022
Q3 		$38K Buy
567
+167
+42% +$14.4K 0.02% 518
2022
Q2 		$30K Buy
400
+267
+201% +$31.2K 0.02% 534
2022
Q1 		$20K Hold
133
– – 0.01% 730
2021
Q4 		$45K Hold
133
– – 0.02% 489
2021
Q3 		$58K Hold
133
– – 0.04% 373
2021
Q2 		$47K Hold
133
– – 0.03% 456
2021
Q1 		$49K Hold
133
– – 0.04% 403
2020
Q4 		$50K Hold
133
– – 0.04% 334
2020
Q3 		$60K Buy
+133
New +$76.6K 0.06% 283

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

Newbridge Financial Services Group's CUE Position: Q1 2026 in Review

Newbridge Financial Services Group held its Cue Biopharma (CUE) position steady in Q1 2026 at 100 shares worth $690. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Newbridge Financial Services Group first reported a position in CUE in Q3 2020 and has held it in 23 quarters since. The position peaked at $60K in Q3 2020. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Newbridge Financial Services Group held 100 shares of Cue Biopharma worth $690 as of Q1 2026.
  • Newbridge Financial Services Group left its Cue Biopharma share count unchanged in Q1 2026.
  • Cue Biopharma made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1098 holding.
  • Newbridge Financial Services Group first reported a position in Cue Biopharma in Q3 2020 and has held it in 23 quarters since.
  • Newbridge Financial Services Group's Cue Biopharma position peaked at $60K in Q3 2020.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.